Phase II Pilot Study of Extracorporeal Phototherapy for Epidermolysis Bullosa Acquisita
NCT00004359 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2005-06-24
Summary
OBJECTIVES: I. Evaluate immunomodulation with extracorporeal photochemotherapy (ECP) in patients with epidermolysis bullosa acquisita.
II. Investigate the effect of ECP on lymphocyte activity.
Conditions
- Epidermolysis Bullosa Acquisita
Interventions
- DRUG
-
methoxsalen
Sponsors & Collaborators
- collaborator OTHER
-
National Center for Research Resources (NCRR)
lead NIH
Principal Investigators
-
Kenneth B. Gordon · Northwestern University
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1996-02-29
More Related Trials
-
The Efficacy and Safety of Secukinumab in Patients With Ichthyoses
NCT03041038 ·Status: COMPLETED ·Phase: PHASE2
-
Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs
NCT01033552 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Metabolic Profiling of Immune Responses in Immune-mediated Diseases
NCT04864886 ·Status: RECRUITING
-
Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa
NCT01538862 ·Status: COMPLETED ·Phase: PHASE2
-
Short Term Observational Study in DEB Patients
NCT02178969 ·Status: COMPLETED
-
Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III)
NCT05838092 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study
NCT03016715 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma)
NCT00442611 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of D-Fi for the Treatment of Wounds Due to DEB
NCT06892639 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants
NCT00433485 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa
NCT05157958 ·Status: RECRUITING ·Phase: PHASE2
-
Pilot Study Evaluating the Efficiency and the Tolerance of the PDT in the Treatment of Epidermal Dysplasia for Patients Affected by Hereditary DEB
NCT02004600 ·Status: WITHDRAWN ·Phase: NA
-
ST266 in UV-induced Inflammation
NCT02389777 ·Status: COMPLETED ·Phase: PHASE2
-
Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study
NCT02960997 ·Status: COMPLETED ·Phase: PHASE2
-
ESSENCE Study: Efficacy and Safety of SD-101 Cream in Participants With Epidermolysis Bullosa
NCT02384460 ·Status: COMPLETED ·Phase: PHASE3
-
N-Acetyl Cysteine in Pathologic Skin Picking
NCT01063348 ·Status: COMPLETED ·Phase: PHASE2
-
Quantification of Calcinosis Cutis Disease Burden Using Computed Tomography Images
NCT07228429 ·Status: RECRUITING
-
Studies of Dermatologic Diseases Biospecimen Acquisition Protocol
NCT02471352 ·Status: RECRUITING
-
A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB)
NCT02810951 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Epidermal Growth Factor Receptor Inhibition for Keratinopathies
NCT06545695 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
T Cell Repertoire Analysis of Immune Mediated Skin Diseases
NCT00368784 ·Status: COMPLETED
-
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
NCT00883129 ·Status: COMPLETED ·Phase: PHASE2
-
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
NCT07287670 ·Status: RECRUITING ·Phase: PHASE2
-
Establishment of the National Epidermolysis Bullosa Registry
NCT00004761 ·Status: COMPLETED
-
Study of Applications of Autologous Epidermal Cells in Liquid Phase in the Treatment of Vitiligo
NCT01511965 ·Status: COMPLETED ·Phase: PHASE1/PHASE2